Dr. Ryan Zarychanski News Archive
![Dr. Frank Plummer poses for the photo in a lab. He is wearing a white coat.](https://news.umanitoba.ca/wp-content/uploads/2013/11/PLUMMER_Frank-150x150.jpg)
Rady Faculty of Health Sciences
Marking 140 years of health research impact
November 17, 2023 —
The Max Rady College of Medicine at UM is marking a milestone. It’s been 140 years since it was founded in 1883 as the Manitoba Medical College, Western Canada’s first medical school.
![Stethoscope on white background.](https://news.umanitoba.ca/wp-content/uploads/2022/04/Stethoscope-150x150.jpg)
Rady Faculty of Health Sciences
Doctors Manitoba Award winners share ties to UM medical college
March 10, 2023 —
The UM medical school is well represented on this year’s list of Doctors Manitoba Award winners.
![A pregnant woman holds her hands on her belly.](https://news.umanitoba.ca/wp-content/uploads/2023/01/UM-Today-Clinical-Trials-Training-150x150.jpg)
Rady Faculty of Health Sciences
Pediatric and pregnancy clinical trials training network to launch
January 19, 2023 —
A scientist from the University of Manitoba has been awarded a national training network to help prepare the next generation of researchers to run clinical trials in the areas of pregnancy and pediatrics.
![Mother is holding her daughter's hand and is checking her child's diabetes by monitoring blood glucose with a device.](https://news.umanitoba.ca/wp-content/uploads/2022/11/UM-Today-CIHR-funding-2022-150x150.jpg)
Rady Faculty of Health Sciences
Rady Faculty research projects receive $6.9-M in CIHR funding
November 28, 2022 —
Six studies led by Rady Faculty of Health Sciences researchers received nearly $7 million in funding from the Canadian Institutes of Health Research (CIHR).
![Illustration of COVID-19 virus.](https://news.umanitoba.ca/wp-content/uploads/2021/08/COVID-19-image-1-150x150.jpg)
Rady Faculty of Health Sciences
Canadian-led international study: Full-dose blood thinners benefit moderately ill COVID-19 patients
August 4, 2021 —
Collaborative international clinical trials testing full-dose anticoagulation with heparin (a blood thinner) in hospitalized patients with COVID-19 has found the treatment improves survival and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients
![](https://news.umanitoba.ca/wp-content/uploads/2021/02/ResearchLifeWinter2021-MCO570047970-Hero1200x800_Heparin_FNL-150x150.jpg)
Research and International
Hip to heparin
March 1, 2021 —
A University of Manitoba research team is emerging as a global leader in COVID-19 anticoagulation trials thanks to their innovative, global trial studying different types of heparin, an anticoagulant (blood thinning) and anti-inflammatory drug
![](https://news.umanitoba.ca/wp-content/uploads/2020/05/23312-150x150.png)
Rady Faculty of Health Sciences
Full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients in international trial
January 22, 2021 —
Treatment expected to reduce the pressure in intensive care units around the world
![](https://news.umanitoba.ca/wp-content/uploads/2020/05/23312-150x150.png)
Rady Faculty of Health Sciences
International trials of blood thinners in critically ill COVID-19 patients pause due to futility
December 22, 2020 —
Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients.
![COVID-19 Virus](https://news.umanitoba.ca/wp-content/uploads/2020/03/cdc-w9KEokhajKw-unsplash-150x150.jpg)
New funding for UM COVID-19 research
June 25, 2020 —
Six University of Manitoba researchers and their teams have received $7.5 million in federal and provincial funding to investigate a range of impacts of the virus on specific populations
![Dr. Ryan Zarychanski.](https://news.umanitoba.ca/wp-content/uploads/2020/04/Awards-R-Zarychanski-e1586202678280-150x150.jpg)
Study finds Hydroxychloroquine no better than placebo
June 3, 2020 —
A study published in the prestigious New England Journal of Medicine has found that the drug hydroxychloroquine does not prevent infection from COVID-19.